Bakrania P - Search Results

1

Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases.

Zhang L, Armour K, Chen JY, Mylona A, Yang M, Andersen GR, Maciejewki JP, Bakrania P, Lin F. Zhang L, et al. Among authors: bakrania p. Mol Immunol. 2024 Jun;170:19-25. doi: 10.1016/j.molimm.2024.03.010. Epub 2024 Apr 10. Mol Immunol. 2024. PMID: 38598870 Free article.

2

Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool.

Sawmynaden K, Wong N, Davies S, Cowan R, Brown R, Tang D, Henry M, Tickle D, Matthews D, Carr M, Bakrania P, Hoi Ting H, Hall G. Sawmynaden K, et al. Among authors: bakrania p. PLoS One. 2023 Jul 17;18(7):e0288259. doi: 10.1371/journal.pone.0288259. eCollection 2023. PLoS One. 2023. PMID: 37459326 Free PMC article.

3

A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/Ritonavir.

Snell LB, McGreal-Bellone A, Nye C, Gage S, Bakrania P, Williams TGS, Aarons E, Botgros A, Douthwaite ST, Mallon P, Milligan I, Moore C, O'Kelly B, Underwood J, de Barra E, Nebbia G. Snell LB, et al. Among authors: bakrania p. Open Forum Infect Dis. 2023 Dec 7;11(1):ofad612. doi: 10.1093/ofid/ofad612. eCollection 2024 Jan. Open Forum Infect Dis. 2023. PMID: 38269048 Free PMC article.

4

Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Snell LB, Alcolea-Medina A, Charalampous T, Alder C, Williams TGS, Flaviani F, Batra R, Bakrania P, Thangarajah R, Neil SJD, van Nispen Tot Pannerden C, Botgros A, Aarons E, Douthwaite ST, Edgeworth JD, Nebbia G. Snell LB, et al. Among authors: bakrania p. Clin Infect Dis. 2023 Mar 21;76(6):1125-1128. doi: 10.1093/cid/ciac864. Clin Infect Dis. 2023. PMID: 36327795 Free PMC article.

5

Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.

Bouter Y, Liekefeld H, Pichlo S, Westhoff AC, Fenn L, Bakrania P, Bayer TA. Bouter Y, et al. Among authors: bakrania p. Acta Neuropathol. 2022 May;143(5):601-603. doi: 10.1007/s00401-022-02418-3. Epub 2022 Apr 16. Acta Neuropathol. 2022. PMID: 35429251 Free PMC article. No abstract available.

6

Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer's disease.

Bakrania P, Hall G, Bouter Y, Bouter C, Beindorff N, Cowan R, Davies S, Price J, Mpamhanga C, Love E, Matthews D, Carr MD, Bayer TA. Bakrania P, et al. Mol Psychiatry. 2022 Feb;27(2):840-848. doi: 10.1038/s41380-021-01385-7. Epub 2021 Nov 15. Mol Psychiatry. 2022. PMID: 34776512

7

The Association of a Single-Nucleotide Polymorphism in the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene With Adverse Drug Reactions, Multimorbidity, and Frailty in Older People.

Scutt G, Overall A, Bakrania P, Krasteva E, Parekh N, Ali K, Davies JG, Rajkumar C. Scutt G, et al. Among authors: bakrania p. J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1050-1057. doi: 10.1093/gerona/glz131. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31102514

8

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X.

Antonios G, Borgers H, Richard BC, Brauß A, Meißner J, Weggen S, Pena V, Pillot T, Davies SL, Bakrania P, Matthews D, Brownlees J, Bouter Y, Bayer TA. Antonios G, et al. Among authors: bakrania p. Sci Rep. 2015 Dec 2;5:17338. doi: 10.1038/srep17338. Sci Rep. 2015. PMID: 26626428 Free PMC article.

9

N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF.

Chapman TM, Wallace C, Gillen KJ, Bakrania P, Khurana P, Coombs PJ, Fox S, Bureau EA, Brownlees J, Melton DW, Saxty B. Chapman TM, et al. Among authors: bakrania p. Bioorg Med Chem Lett. 2015 Oct 1;25(19):4104-8. doi: 10.1016/j.bmcl.2015.08.024. Epub 2015 Aug 14. Bioorg Med Chem Lett. 2015. PMID: 26321360

10

Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF.

Chapman TM, Gillen KJ, Wallace C, Lee MT, Bakrania P, Khurana P, Coombs PJ, Stennett L, Fox S, Bureau EA, Brownlees J, Melton DW, Saxty B. Chapman TM, et al. Among authors: bakrania p. Bioorg Med Chem Lett. 2015 Oct 1;25(19):4097-103. doi: 10.1016/j.bmcl.2015.08.031. Epub 2015 Aug 17. Bioorg Med Chem Lett. 2015. PMID: 26318993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page